SmithRx logo

SmithRx

SmithRx is a pharmacy benefit manager that runs drug benefits for employers on a fixed fee basis and passes all rebates and discounts back to clients.

ShareLink copied

The record

Vertical
Payer
Sub-segment
Pass through pharmacy benefit management
Product type
Service
Stage
Series C+
Headquarters
San Francisco, California
Region
North America
Founded
2016

What they do

SmithRx was founded in 2016 and is based in San Francisco. Founder and CEO Jake Frenz previously worked at Collective Health and Anthem. The company manages prescription drug benefits for self insured employers and health plans, charging an administrative fee instead of earning spread pricing, and passing 100 percent of rebates through to the plan sponsor. Its programs include Autoimmune Savings and Low Cost Insulin, and it has partnered with Mark Cuban Cost Plus Drug Company and Amazon Pharmacy. SmithRx raised a $20 million Series B in 2022 and a $60 million Series C in January 2024, both led by Venrock.

Leadership & founders

Leadership as of 14 November 2026.

Investors

In The HealthTech Signal

Related companies

Is this your company? Get a Verified profile